Oklahoma attempts to return $2M surplus of hydroxychloroquine

Published



The Oklahoma attorney general’s office said it will attempt to return a $2 million stockpile worth of hydroxychloroquine, the anti-malarial drug once described by former President Donald Trump as a potential treatment for COVID-19, a spokesman said Wednesday.

The stockpile of 1.2 million hydroxychloroquine pills was sent to Oklahoma in April from a supplier in California, FFF Enterprises, a private pharmaceutical company, the Frontier reported.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.